Key result
A 56-year-old man with primary cardiac diffuse large B-cell lymphoma was successfully treated with dose-dense R-CHOP-14 chemotherapy and rituximab, achieving remission for over 3 years.
Population
56-year-old man with acute onset of sepsis and ventricular fibrillation, diagnosed with primary cardiac…
Design
Case_report
Follow-up
>3 years
Authors
Loading...
Case suggests R-CHOP-14 feasibility in primary cardiac DLBCL; hypothesis-generating and requires prospective validation before practice change.
Case Report (n=1)
Multimodality imaging including echocardiography and CMR successfully guided the diagnosis of a rare primary cardiac B-cell lymphoma, which was effectively treated with R-CHOP-14 chemotherapy.
Menke et al. (2011) conducted a case report in Primary cardiac diffuse large B-cell lymphoma (n=1). R-CHOP-14 protocol (cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab) was evaluated on Resolution of cardiac lymphoma and remission. A 56-year-old man with primary cardiac diffuse large B-cell lymphoma was successfully treated with dose-dense R-CHOP-14 chemotherapy and rituximab, achieving remission for over 3 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: